RIS
BBIO icon

Retirement Income Solutions’s BridgeBio Pharma BBIO Stock Holding History

Retirement Income Solutions’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$267K Hold
3,599
– – 0.05% 137
2026
Q1 		$267K Hold
3,599
– – 0.05% 138
2025
Q4 		$275K Sell
3,599
-1,401
-28% -$92K 0.05% 136
2025
Q3 		$260K Hold
5,000
– – 0.04% 138
2025
Q2 		$216K Buy
+5,000
New +$182K 0.04% 146

Other funds holding BBIO

JT
Jupiter Topco New York $245B AUM
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return

Retirement Income Solutions's BBIO Position: Q2 2026 in Review

Retirement Income Solutions held its BridgeBio Pharma (BBIO) position steady in Q2 2026 at 3,599 shares worth $267K. The position accounts for 0.05% of the portfolio, ranked #137.

Retirement Income Solutions first reported a position in BBIO in Q2 2025 and has held it in 5 quarters since. The position peaked at $275K in Q4 2025. 474 funds tracked by Wall St. Rank hold BBIO as of Q2 2026.

  • Retirement Income Solutions held 3,599 shares of BridgeBio Pharma worth $267K as of Q2 2026.
  • Retirement Income Solutions left its BridgeBio Pharma share count unchanged in Q2 2026.
  • BridgeBio Pharma made up 0.05% of Retirement Income Solutions's portfolio in Q2 2026, its #137 holding.
  • Retirement Income Solutions first reported a position in BridgeBio Pharma in Q2 2025 and has held it in 5 quarters since.
  • Retirement Income Solutions's BridgeBio Pharma position peaked at $275K in Q4 2025.
  • 474 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q2 2026.

Based on Retirement Income Solutions's 13F filing for Q2 2026, filed 3 Aug 2026.